Alterations in serum amino acid profiles in children with attention deficit/hyperactivity disorder

The objective of the present study was to evaluate the circulating serum amino acid levels in children with attention deficit/hyperactivity disorder (ADHD). A total of 71 children with untreated ADHD and 31 neurotypical controls aged 7-14 years old were examined. Serum amino acid levels were evaluated using high-performance liquid chromatography (HPLC) with UV-detection. Laboratory quality control was performed with reference materials of human plasma amino acid levels. The obtained data demonstrated that children with ADHD were characterized by 29, 10 and 20% lower serum histidine (His), glutamine (Gln) and proline (Pro) levels compared with neurotypical children, respectively. In contrast, circulating aspartate (Asp), glutamate (Glu) and hydroxyproline (Hypro) levels exceeded the respective control values by 7, 7 and 42%. Correspondingly, the Gln-to-Glu and Pro-to-Hypro ratios were 28% and 49%, respectively, lower in ADHD cases compared with the controls. Total Gln/Glu levels were also significantly lower in ADHD patients. No significant group differences were observed between the groups in the other amino acids analyzed, including phenylalanine. Multiple linear regression analysis revealed significant associations between circulating serum Gln, lysine (Lys) (both negative) and Glu (positive) levels with total ADHD Rating Scale-IV scores. The observed alterations in Pro/Hypro and Gln/Glu levels and ratios are likely associated with the coexisting connective tissue pathology and alterations in glutamatergic neurotransmission in ADHD, respectively. Altered circulating levels of His, Lys and Asp may also be implicated in ADHD pathogenesis. However, further in vivo and in vitro studies are required in order to investigate the detailed mechanisms linking amino acid metabolism with ADHD pathogenesis. © 2021, Spandidos Publications. All rights reserved.

Skalny A.V. 1, 2 , Mazaletskaya A.L.1 , Zaitseva I.P.1 , Skalny A.A. 3 , Spandidos D.A.4 , Tsatsakis A.2, 5 , Lobanova Y.N. 3 , Skalnaya M.G. 1 , Aschner M. 2, 6 , Tinkov A.A. 1, 2
Spandidos Publications
Номер выпуска
  • 1 Laboratory of Biotechnology and Applied Bioelementology, Yaroslavl State University, Yaroslavl, 150000, Russian Federation
  • 2 Laboratory of Molecular Dietetics, IM Sechenov First Moscow State Medical University, Sechenov University, Moscow, 119435, Russian Federation
  • 3 Department of Medical Elementology, Peoples' Friendship, University of Russia (RUDN University), Moscow, 117198, Russian Federation
  • 4 Laboratory of Clinical Virology, University of Crete, Heraklion, 70013, Greece
  • 5 Center of Toxicology Science and Research, Medical School, University of Crete, Heraklion, 70013, Greece
  • 6 Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461, United States
Ключевые слова
Attention deficit/hyperactivity disorder; Glutamine; Hydroxyproline; Lysine; Neurodevelopmental disorder
Дата создания
Дата изменения
Постоянная ссылка

Другие записи